Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis

Rajesh K. Thimmulappa(Johns Hopkins University)

Journal of Clinical Investigation

March 23, 2006

10.1172/jci25790

Cited by 1,035

Related Papers

Decline in NRF2-regulated Antioxidants in Chronic Obstructive Pulmonary Disease Lungs Due to Loss of Its Positive Regulator, DJ-1

|American Journal of Respiratory and Critical Care Medicine|2008|354

NRF2 signaling is repressed in HPV-driven head and neck cancer and correlates with better prognosis: HPV-E6/E7 confers chemosensitivity by inhibiting NRF2

|Research Square|2022|1

Human Papillomavirus-driven repression of NRF2 signaling confers chemosensitivity and predicts prognosis in head and neck squamous cell carcinoma

|Research Square|2022|0